Squarepoint’s ChemoCentryx, Inc. CCXI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-14,287
Closed -$354K 3633
2022
Q2
$354K Sell
14,287
-14,616
-51% -$322K ﹤0.01% 2195
2022
Q1
$725K Sell
28,903
-63,436
-69% -$1.78M ﹤0.01% 1786
2021
Q4
$3.36M Buy
92,339
+29,401
+47% +$1.03M 0.01% 970
2021
Q3
$1.08M Sell
62,938
-156,465
-71% -$2.44M ﹤0.01% 1529
2021
Q2
$2.94M Buy
+219,403
New +$5.41M 0.01% 977
2020
Q4
Sell
-62,458
Closed -$3.42M 3387
2020
Q3
$3.42M Buy
+62,458
New +$3.36M 0.05% 459
2020
Q2
Sell
-5,423
Closed -$218K 2617
2020
Q1
$218K Sell
5,423
-51,970
-91% -$2.21M 0.01% 1442
2019
Q4
$2.27M Sell
57,393
-67,292
-54% -$1.18M 0.01% 838
2019
Q3
$845K Sell
124,685
-94,015
-43% -$706K 0.01% 1347
2019
Q2
$2.03M Buy
218,700
+151,482
+225% +$1.75M 0.02% 835
2019
Q1
$934K Sell
67,218
-4,185
-6% -$47.9K 0.01% 1145
2018
Q4
$779K Sell
71,403
-16,572
-19% -$175K 0.01% 1033
2018
Q3
$1.11M Buy
87,975
+3,821
+5% +$46K 0.01% 944
2018
Q2
$1.11M Buy
+84,154
New +$1.01M 0.01% 856
2018
Q1
Sell
-22,574
Closed -$134K 2299
2017
Q4
$134K Buy
22,574
+9,418
+72% +$64.6K ﹤0.01% 1899
2017
Q3
$98K Buy
+13,156
New +$109K ﹤0.01% 1515

Other funds holding CCXI

Squarepoint's CCXI Position: Q3 2022 in Review

Squarepoint sold out of ChemoCentryx, Inc. (CCXI) in Q3 2022, closing a stake of 14,287 shares — an estimated $354K sold.

Squarepoint first reported a position in CCXI in Q3 2017 and held it in 16 quarters. The position peaked at $3.42M in Q3 2020. 217 funds tracked by Wall St. Rank hold CCXI as of Q3 2022.

  • Squarepoint reported no remaining ChemoCentryx, Inc. position as of Q3 2022 after selling out during the quarter.
  • Squarepoint sold 14,287 ChemoCentryx, Inc. shares in Q3 2022, an estimated $354K.
  • Squarepoint first reported a position in ChemoCentryx, Inc. in Q3 2017 and held it in 16 quarters.
  • Squarepoint's ChemoCentryx, Inc. position peaked at $3.42M in Q3 2020.
  • 217 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2022.

Based on Squarepoint's 13F filing for Q3 2022, filed 14 Nov 2022.